Third Harmonic Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	269.52	289.32	128.28	8.28
Cash & Cash Equivalents	269.52	289.32	128.28	8.28
Cash Growth	-6.84%	125.54%	1449.84%	-
Other Current Assets	2.92	3.52	0.88	0.16
Total Current Assets	272.45	292.84	129.16	8.43
Property, Plant & Equipment	3.93	4.36	0	0
Other Long-Term Assets	1.33	1.48	0	0
Total Long-Term Assets	5.27	5.84	0	0
Total Assets	277.71	298.68	129.16	8.43
Accounts Payable	1.84	2.09	1.8	0.58
Current Debt	0.75	0.39	0	0
Other Current Liabilities	2.84	3.18	3.89	1.63
Total Current Liabilities	5.42	5.65	5.69	2.21
Long-Term Debt	3.21	3.95	0	0
Other Long-Term Liabilities	0	0	0	5.88
Total Long-Term Liabilities	3.21	3.95	0	5.88
Total Liabilities	8.63	9.61	5.69	8.09
Total Debt	3.95	4.34	0	0
Debt Growth	-8.90%	-	-	-
Retained Earnings	-114.22	-83.4	-48.24	-18.63
Shareholders' Equity	269.09	289.07	-46.71	-18.36
Net Cash / Debt	265.57	284.98	128.28	8.28
Net Cash / Debt Growth	-6.81%	122.15%	1449.84%	-
Net Cash Per Share	6.70	19.85	31.73	1.00
Working Capital	267.03	287.18	123.48	6.22
Book Value Per Share	6.79	20.14	-11.55	-2.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).